DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Givinostat - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Givinostat - Emerging Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product...
August 2020
80 pages
Inclisiran - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Inclisiran - Emerging Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product...
August 2020
80 pages
Casimersen - Drug Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Casimersen - Emerging Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product...
August 2020
80 pages
Idebenone - Drug Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours OVERVIEW “Idebenone - Emerging Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product i...
August 2020
80 pages
Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor -Pipeline Insight, 2020
US$ 1,500.00
... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor The ...
June 2020
120 pages
Vascular Adhesion Protein 1 (VAP-1) Inhibitor -Pipeline Insight, 2020
US$ 1,500.00
... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Vascular Adhesion Protein 1 (VAP-1) Inhibitor The ...
June 2020
60 pages
Mayus Kinase 1 (JAK1) Inhibitor -Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48 hours OVERVIEW 'Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2020' report by DelveInsight outlays comprehensive insights of present scena...
June 2020
90 pages
Mayus Kinase 3 (JAK3) Inhibitor -Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48 hours OVERVIEW 'Mayus Kinase 3 (JAK3) Inhibitor - Pipeline Insight, 2020' report by DelveInsight outlays comprehensive insights of present scena...
June 2020
60 pages
Mayus Kinase (JAK) Inhibitor -Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48 hours OVERVIEW 'Mayus Kinase (JAK) Inhibitor - Pipeline Insight, 2020' report by DelveInsight outlays comprehensive insights of present scenario...
June 2020
60 pages
Casimersen - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “Casimersen - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...
April 2020
60 pages
Idebenone - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “Idebenone - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product f...
April 2020
60 pages
PF-06939926 - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “PF-06939926 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...
April 2020
60 pages
SAGE-217 - Emerging Insight and Market Forecast – 2028
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “SAGE-217 - Emerging Insight and Market Forecast – 2028” the report provides comprehensive insights about an investigational product fo...
April 2020
60 pages
SRP-9001 - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “SRP-9001 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product fo...
April 2020
60 pages
Vamorolone - Emerging Insight and Market Forecast – 2030
US$ 3,250.00
This report can be delivered to the clients within 24-48 Hours “Vamorolone - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product...
April 2020
60 pages
Cytomegalovirus (HHV-5) Infections - Pipeline Insight, 2019
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cytomegalovirus (HHV-5) Infections The report also ...
February 2020
106 pages
Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2019
US$ 1,250.00
... clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Varicella Zoster (HHV-3) Infections by development stage, therapy type, route of administration and molecule type is also covered in the ...
February 2020
106 pages
Hepatic - Colorectal Metastasis - Pipeline Insight, 2019
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hepatic - Colorectal Metastasis The report also ...
February 2020
106 pages
Fanconi Anemia (FA) - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Fanconi Anemia (FA) Overview 'Fanconi Anemia (FA) Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Pres...
February 2020
106 pages
Hallux Valgus - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Hallux Valgus Overview 'Hallux Valgus Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical...
February 2020
106 pages
Keratoconus - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Keratoconus Overview 'Keratoconus Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Dev...
February 2020
106 pages
Muscle Invasive Bladder cancer- Pipeline Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours Muscle Invasive Bladder cancer Overview 'Muscle Invasive Bladder cancer Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehe...
February 2020
106 pages
Opioid Overdose - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Opioid Overdose Overview 'Opioid Overdose Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clin...
February 2020
106 pages
Sialorrhea- Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Sialorrhea Overview 'Sialorrhea Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Devel...
February 2020
106 pages
Tay-Sachs Disease - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Tay-Sachs Disease Overview 'Tay-Sachs Disease Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present...
February 2020
106 pages
Varicose Ulcer - Pipeline Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours Varicose Ulcer Overview 'Varicose Ulcer Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clinic...
February 2020
106 pages
Vaso-Occlusive Crisis - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Vaso-Occlusive Crisis Overview 'Vaso-Occlusive Crisis Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of...
February 2020
106 pages
Wilms Tumor - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Wilms Tumor Overview 'Wilms Tumor Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Dev...
February 2020
106 pages
Abdominal Aortic Aneurysm - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Abdominal Aortic Aneurysm Overview 'Abdominal Aortic Aneurysm Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insi...
February 2020
106 pages
Abscess - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Abscess Overview 'Abscess Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development...
February 2020
106 pages
Acquired Blepharoptosis - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Acquired Blepharoptosis Overview 'Acquired Blepharoptosis Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights...
February 2020
106 pages
Acute Heart failure (AHF) - Pipeline Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours Acute Heart failure (AHF) Overview 'Acute Heart failure (AHF) Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insi...
February 2020
106 pages
Acute Kidney Injury (AKI) - Pipeline Insight, 2020
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours Acute Kidney Injury (AKI) Overview 'Acute Kidney Injury (AKI) Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insi...
February 2020
106 pages
Acute Myeloid Leukemia (AML) - Pipeline Insight, 2020
US$ 2,500.00
This report can be delivered to the clients within 48-72 Hours Acute Myeloid Leukemia (AML) Overview 'Acute Myeloid Leukemia (AML) Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensiv...
February 2020
106 pages
Adrenal Insufficiency - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours Adrenal Insufficiency Overview 'Adrenal Insufficiency Pipeline Insight, 2020' Report By DelveInsight Outlays Comprehensive Insights Of...
February 2020
106 pages
